Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 9319
Gene Symbol: TRIP13
TRIP13 		0.300 Biomarker phenotype CTD_human Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation. 28553959 2017
Entrez Id: 701
Gene Symbol: BUB1B
BUB1B 		0.300 Biomarker phenotype CTD_human Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation. 28553959 2017
Entrez Id: 1761
Gene Symbol: DMRT1
DMRT1 		0.300 Biomarker phenotype CTD_human Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. 20543847 2010
Entrez Id: 55729
Gene Symbol: ATF7IP
ATF7IP 		0.300 Biomarker phenotype CTD_human Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. 20543847 2010
Entrez Id: 2067
Gene Symbol: ERCC1
ERCC1 		0.300 Biomarker phenotype CTD_human ERCC1 and XPF expression in human testicular germ cell tumors. 19956886 2010
Entrez Id: 2072
Gene Symbol: ERCC4
ERCC4 		0.300 Biomarker phenotype CTD_human ERCC1 and XPF expression in human testicular germ cell tumors. 19956886 2010
Entrez Id: 4254
Gene Symbol: KITLG
KITLG 		0.300 Biomarker phenotype CTD_human Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. 19483682 2009
Entrez Id: 4254
Gene Symbol: KITLG
KITLG 		0.300 Biomarker phenotype CTD_human A genome-wide association study of testicular germ cell tumor. 19483681 2009
Entrez Id: 5460
Gene Symbol: POU5F1
POU5F1 		0.300 Biomarker phenotype CTD_human Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. 16168501 2005
Entrez Id: 79923
Gene Symbol: NANOG
NANOG 		0.300 Biomarker phenotype CTD_human Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. 16168501 2005
Entrez Id: 359787
Gene Symbol: DPPA3
DPPA3 		0.300 Biomarker phenotype CTD_human Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. 16168501 2005
Entrez Id: 928
Gene Symbol: CD9
CD9 		0.300 Biomarker phenotype CTD_human Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. 16168501 2005
Entrez Id: 6337
Gene Symbol: SCNN1A
SCNN1A 		0.300 Biomarker phenotype CTD_human Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. 16168501 2005
Entrez Id: 6515
Gene Symbol: SLC2A3
SLC2A3 		0.300 Biomarker phenotype CTD_human Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. 16168501 2005
Entrez Id: 9573
Gene Symbol: GDF3
GDF3 		0.300 Biomarker phenotype CTD_human Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. 16168501 2005
Entrez Id: 1911
Gene Symbol: PHC1
PHC1 		0.300 Biomarker phenotype CTD_human Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. 16168501 2005
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.010 GeneticVariation phenotype BEFREE TP53 is the most frequently mutated gene in human malignancies; however, de novo somatic mutations in childhood embryonal cancers such as neuroblastoma are rare. 24634504 2014
Entrez Id: 3481
Gene Symbol: IGF2
IGF2 		0.010 Biomarker phenotype BEFREE Analysis of microarray data showed elevated expression of MEST, PLAGL1, PEG3, DLK1, and IGF2 in various embryonal cancers, especially rhabdomyosarcoma, as compared to nonembryonal cancers and normal tissues. 22289848 2012
Entrez Id: 3558
Gene Symbol: IL2
IL2 		0.010 AlteredExpression phenotype BEFREE To understand T cell-mediated specific immunity at the tumor site of testicular embryonal cancer, we investigated whether interleukin-2 (IL-2)-activated tumor-infiltrating lymphocytes (TIL) of a patient with testicular embryonal cancer show histocompatibility leukocyte antigen (HLA)-class I-restricted and tumor-specific cytotoxicity. 9473736 1997